Tempus Expands Data & Sequencing Collaboration with Remix Therapeutics
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, announced an expanded collaboration with Remix Therapeutics, a clinical-stage biotechnology company developing...
